Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Paclitaxel + Avelumab for Inoperable Angiosarcoma
KCT0003334Phase 2Completed
- Sponsor
- Dong-A University Hospital
- Start
- Jun 2019
- Modality
- Small Molecules, Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, avelumab in angiosarcoma, sponsored by Dong-A University Hospital. Started Jun 2019; status: completed.
02
Drugs
paclitaxelavelumab
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on KCT0003334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003334.